Annual report pursuant to Section 13 and 15(d)

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

12 Months Ended

Dec. 31, 2020

Prepaid Expense And Other Assets Current [Abstract]

Prepaid Expenses and Other Current Assets

(4)	Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:

		December 31, 2020				December 31, 2019
Refundable FDA filing fee (1)		$	2,876				-
Short-term deposits			2,360				1,139
Research and development tax credit receivable			801				1,036
Prepaid research and development expenses			157				1,679
Prepaid insurance			415				569
Value added tax receivable			64				68
Other prepaid assets			231				57
Deferred financing expenses			—				2,339
Total		$	6,904			$	6,887
(1) FDA filing fee refund of $2,876 was received in January 2021